Quince Therapeutics
QNCX
QNCX
40 hedge funds and large institutions have $13.5M invested in Quince Therapeutics in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
30% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 10
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
Holders
40
Holding in Top 10
–
Calls
$167K
Puts
$2K
Top Buyers
| 1 | +$2.12M | |
| 2 | +$344K | |
| 3 | +$222K | |
| 4 |
Renaissance Technologies
New York
|
+$88.5K |
| 5 |
IP
Intellectus Partners
San Francisco,
California
|
+$80.6K |
Top Sellers
| 1 | -$322K | |
| 2 | -$281K | |
| 3 | -$86.6K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$82.8K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$73K |